Profile
APYX ABT BSX-PA BSX SYK MDT
Company Name Apyx Medical Corporation Abbott Laboratories Boston Scientific Corporation Boston Scientific Corporation Stryker Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $36.85M $223.47B $175.45B $150.72B $129.62B $107.94B
Employees 0.22K 114.00K 45.00K 53.00K 53.00K 95.00K
CEO Mr. Charles D. Goodwin II Mr. Robert B. Ford Mr. Michael F. Mahoney Mr. Michael F. Mahoney Mr. Kevin A. Lobo Mr. Geoffrey Straub Martha
Ratings
APYX ABT BSX-PA BSX SYK MDT
Quant Rating Score 2 4 1 3 3
Quant Rating Sell Buy Strong Sell Neutral Neutral
Trading
APYX ABT BSX-PA BSX SYK MDT
Last Close $0.8905 $128.85 $122.18 $101.9 $365.06 $84.16
High 52 $1.9 $140.22 $122.18 $106.18 $399.9 $94.5
Low 52 $0.86 $100.07 $122.18 $71.87 $315.94 $76.84
Price vs. 52 Week High -53.13 % -8.11 % 0 % -4.03 % -8.71 % -10.94 %
Price vs. 52 Week Low 3.55 % 28.76 % 0 % 41.78 % 15.55 % 9.53 %
Total Return
APYX ABT BSX-PA BSX SYK MDT
1 Month Return -29.88 % 1.77 % 0 % -0.43 % -0.74 % -4.61 %
3 Month Return -40.23 % 3.06 % 0 % -0.04 % -7.42 % -6.69 %
6 Month Return -26.4 % 12.81 % 0 % 20.26 % 3.47 % -7.1 %
9 Month Return -33.54 % 22.43 % 0 % 36.01 % 10.07 % 6.94 %
YTD Return -43.64 % 13.92 % 0 % 14.08 % 1.39 % 5.36 %
1 Year Return -38.59 % 19.83 % 0 % 39.26 % 8.78 % 5.54 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
APYX ABT BSX-PA BSX SYK MDT
Dividend Yield Percentage (TTM) - 1.77 % - - 0.97 % 3.33 %
Dividend Paid and Capex Coverage Ration (TTM) -25 % 1.42 % 3.37 % 3.37 % 2.15 % 1.34 %
Dividend Per Share (TTM) - 2.28 % - - 3.28 % 2.8 %
Payout Ratio (TTM) - 28.62 % 1.24 % 1.13 % 40.73 % 84.62 %
Growth
APYX ABT BSX-PA BSX SYK MDT
Asset Growth -18.17 % 11.2 % 12.12 % 7.66 % -1.06 %
Gross Profit Growth -13.03 % 5.01 % 16.12 % 10.25 % 3.12 %
Revenue Growth -8.11 % 4.59 % 17.61 % 10.23 % 3.64 %
Revenue 3 Year -4.23 % -0.18 % 36.16 % 30.69 % 8.85 %
Revenue 5 Year 63.77 % 34.24 % 47.52 % 49.02 % 7.41 %
Revenue 10 Year -13.54 % 80.43 % 104.22 % 132.01 % 43.65 %
EBIT Growth -9.19 % 5.36 % 11.1 % -5.12 % -6.22 %
Net Income Growth -25.38 % 134.18 % 16.32 % -5.43 % -2.18 %
Net Income 3 Yeari Growth Per Share -49.11 % 94.27 % 72.05 % 48.52 % 3.26 %
Net Income 5 Yeari Growth Per Share -14.46 % 271.11 % -62.72 % 41.05 % -19.5 %
Net Income 10 Yeari Growth Per Share 32.45 % 410.99 % 524.58 % 477.35 % -9.48 %
Operating Income Growth -9.19 % 5.36 % 11.1 % -5.12 % -6.22 %
Operating Cash Flow Growth (CFG) -243.82 % 17.86 % 37.24 % 14.31 % 12.39 %
Operating 3 Year CFG -66.84 % -16.72 % 77.55 % 28.64 % 10.18 %
Operating 5 Year CFG 6.37 % 42.4 % 76.92 % 90.05 % -1.78 %
Operating 10 Year CFG -2053.25 % 102.79 % 143.61 % 136.49 % 3.3 %
EPS Growth -22.22 % 134.55 % 16.67 % -5.76 % -2.12 %
EPS Diluted Growth -22.22 % 134.56 % 16.82 % -5.94 % -2.13 %
Book Value Per Share -48.13 % 23.54 % 11.25 % 10.57 % -2.26 %
Share Holder 3 Year Equity Growth Per Share -74.44 % 36.46 % 26.58 % 37.24 % -1.1 %
Share Holder 5 Year Equity Growth Per Share -80.89 % 56.53 % 48.35 % 58.15 % 1.66 %
Share Holder 10 Year Equity Growth Per Share 50.62 % 92.83 % 186.31 % 138.47 % 94.93 %
Dividend Per Share Growth - 8.02 % -100 % 6.63 % 1.54 %
Dividend 3 Year Growth Per Share - 22.8 % -100 % 26.97 % 19.02 %
Dividend 5 Year Growth Per Share - 72.53 % - 53.81 % 38.05 %
Dividend 10 Year Growth Per Share - 148.92 % - 162.12 % 147.94 %
Debt Growth -87.35 % -5.37 % 13.21 % -89.16 % 6.91 %
Free Cash Flow Growth -224.61 % 25.54 % 55.31 % 11.19 % 13.54 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024 26 Apr 2024
Profitability
APYX ABT BSX-PA BSX SYK MDT
Gross Profit Margin TTM 47.1 % 55.59 % 67.02 % 67.15 % 62.84 % 62.89 %
Return on Assets TTM -36.18 % 16.46 % 4.7 % 5.16 % 6.97 % 4.73 %
Return on Equity TTM -155.77 % 32.37 % 8.94 % 9.82 % 15.02 % 8.69 %
Return on Capital Employed TTM -34.82 % 10.32 % 8.63 % 9.32 % 10.75 % 7.74 %
Net Income Per EBT TTM 100.67 % 191.1 % 81.07 % 81.97 % 85.71 % 81.56 %
EBT Per Ebit TTM 123.68 % 101.01 % 80.13 % 80.59 % 91.89 % 86.39 %
EBIT Per Revenue TTM -35.97 % 16.55 % 17.01 % 17.52 % 16.82 % 18.21 %
Cash Flow To Debt Ratio TTM -46.56 % 56.97 % 30.82 % 30.82 % 31.2 % 27.41 %
Receivables Turnover TTM 3.38 4.42 6.55 6.86 5.67 5.43
Payables Turnover TTM 10.6 4.44 5.75 6.01 5 5.39
Inventory Turnover TTM 3.66 3.01 1.97 2.05 1.76 2.2
Fixed Asset Turnover TTM 777.63 % 393.6 % 447.28 % 468.83 % 655.31 % 503.55 %
Asset Turnover TTM 80.81 % 51.53 % 42.51 % 44.56 % 52.58 % 36.9 %
Operating Cash Flow Per Share TTM -0.47 4.94 2.33 2.33 11.13 5.69
Free Cash Flow Per Share TTM -0.49 3.67 1.66 1.65 9.15 4.26
Cash Per Share TTM 83.06 % 460.07 % 28.12 % 28.03 % 1155.38 % 617.75 %
Operating Cash Flow Sales Ratio TTM -34.44 % 20.4 % 20.51 % 19.57 % 18.77 % 21.97 %
Free Cash Flow Operating Cash Flow Ratio TTM 104 % 74.21 % 70.98 % 70.98 % 82.2 % 74.96 %
Cash Flow Coverage Ratios TTM -46.56 % 56.97 % 30.82 % 30.82 % 31.2 % 27.41 %
Price To Free Cash Flows Ratio TTM -1.96 35.19 57.79 61.82 37.17 19.74
Price To Operating Cash Flows Ratio TTM -2.06 26.07 40.82 43.82 30.5 14.8
Price Cash Flow Ratio TTM -2.06 26.07 40.82 43.82 30.5 14.8
Income Statement (TTM)
APYX ABT BSX-PA BSX SYK MDT
Revenue $0.05B $41.95B $16.75B $16.75B $22.6B $32.36B
Gross Profit $0.03B $23.24B $11.49B $11.49B $14.44B $21.15B
Gross Profit Ratio 61.04% 55.41% 68.61% 68.61% 63.91% 65.34%
EBITDA $-0.02B $10.83B $2.6B $2.6B $5.72B $8.2B
Net Income $-0.02B $13.4B $1.85B $1.85B $2.99B $3.68B
EPS Diluted -0.66 7.64 1.25 1.25 7.76 2.76
Balance Sheet (MRQ)
APYX ABT BSX-PA BSX SYK MDT
Long Term Debt $0B $13.52B $8.97B $8.97B $0B $24.77B
Total Liabilities $0.05B $33.51B $17.39B $17.39B $22.34B $39.56B
Total Equity $0.01B $47.9B $22B $22B $20.63B $50.42B
Total Investments $0B $1.24B $0.56B $0.56B $0.75B $8.34B
Total Debt $0B $15.02B $10.75B $10.75B $1.41B $26.05B
Total Assets $0.06B $81.41B $39.4B $39.4B $42.97B $89.98B
Cash Flow Statement (TTM)
APYX ABT BSX-PA BSX SYK MDT
Net Income $-0.02B $13.4B $1.85B $1.85B $2.99B $3.68B
Inventory $0B $-0.06B $-0.23B $-0.23B $0.05B $-0.14B
Dividends Paid $0B $-3.84B $0B $0B $-1.22B $-3.67B
Operating Cash Flow $-0.02B $8.56B $3.44B $3.44B $4.24B $6.79B
Capital Expenditure $-0B $-2.21B $-0.79B $-0.79B $-0.76B $-1.59B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 128.85
ADGM Adagio Medical Holdings, Inc. 1.3
AEMD Aethlon Medical, Inc. 0.3813
AFIB Acutus Medical, Inc. 0.041
AHCO AdaptHealth Corp. 8.41
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 183.35
ALUR Allurion Technologies Inc. 2.4
AMIX Autonomix Medical, Inc. Common Stock 2.08
ANIK Anika Therapeutics, Inc. 14.43
AORT Artivion, Inc. 23.84
APEN Apollo Endosurgery, Inc. 10
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 11.51
AVNS Avanos Medical, Inc. 12.35
AVR Anteris Technologies Global Corp. Common Stock 4.98
AXDX Accelerate Diagnostics, Inc. 0.5775
AXGN AxoGen, Inc. 16.4
AXNX Axonics, Inc. 70.98
ETFs With Exposure to APYX
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 270.64
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00031 120.13
VXF Vanguard Extended Market Index Fund 0 170
ONEQ Fidelity Nasdaq Composite Index ETF 0 68.4
IWC iShares Micro-Cap ETF 0.00809 110.33
VTWG Vanguard Russell 2000 Growth Index Fund 0.02 184.33
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 92.08
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 92.07
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 46.34
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 46.33
VBINX Vanguard Balanced Index Fund Investor Shares 0 46.33
AVUS Avantis U.S. Equity ETF 0 90.17
DFAU Dimensional US Core Equity Market ETF 0.000017 37.72
DFAS Dimensional U.S. Small Cap ETF 0.00018778 57.7
DFAC Dimensional U.S. Core Equity 2 ETF 0.00001069 32.09
VTSAX Vanguard Total Stock Market Index Fund 0 131.81
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 128.99
VITSX Vanguard Total Stock Market Index Fund 0 131.83
QQQS Invesco NASDAQ Future Gen 200 ETF 0.27 23.12
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000088238 92.89
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 129
VEMPX Vanguard Extended Market Index InstlPlus 0 318.32
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 247.3
Unlock